FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4224870304> ?p ?o ?g. }

• W4224870304 endingPage "961" @default.
• W4224870304 startingPage "949" @default.
• W4224870304 abstract "Background: Recent studies have reported a wide spectrum of ocular surface injuries in the context of autoimmune reactions in Graves' orbitopathy (GO). Increased expression of inflammatory mediators in tears of GO patients suggests that the lacrimal glands could be a target for immune responses. However, the immunophenotype for GO lacrimal microenvironment is not known. This study aimed to elucidate the pathological changes of GO lacrimal glands. Methods: In this case–control study, lacrimal glands were surgically collected from GO patients who underwent orbital decompression surgery and control subjects who underwent other ocular-related surgery. Bulk RNA-sequencing, flow cytometry with dimensional reduction, and immunohistochemical and multiplexed stainings were conducted. Western blotting and multipathway assays were performed in CD34+ fibroblasts derived from lacrimal and orbital tissues. Results: Increased expression of cytokines and chemokines accompanied by a variety of immune cell infiltrations mainly involving T cells, B cells, and monocytes was found in GO lacrimal glands. An in-depth investigation into T cell subsets revealed interferon (IFN)-γ-producing T helper (Th)1 and interleukin (IL)-17A-producing Th17 cell-dominated autoimmunity in the active GO lacrimal microenvironment. Both fibrosis and adipogenesis were observed in GO lacrimal tissue remodeling. IL-17A, not IFN-γ, stimulated transforming growth factor-β-initiated myofibroblast differentiation as well as 15-deoxy-Δ12,14-prostaglandin J2-initiated adipocyte differentiation in CD34+ lacrimal fibroblasts (LFs) and orbital fibroblasts (OFs), respectively. IL-17A activated many fibrotic and adipogenic-related signaling pathways in CD34+ LFs and OFs. A novel anti-IL-17A monoclonal antibody SHR-1314 could reverse the promoting effect of IL-17A on fibrosis and adipogenesis in CD34+ LFs and OFs. Conclusions: Our findings provide evidence for the infiltration of different lymphocytes into GO lacrimal microenvironment, where Th1 and Th17 cells characterize the onset of active lacrimal inflammation and contribute to tissue remodeling. These findings may have potential future therapeutic implications regarding the utility of anti-IL-17A therapy, which should be studied in future research." @default.
• W4224870304 created "2022-04-27" @default.
• W4224870304 creator A5003642180 @default.
• W4224870304 creator A5022147066 @default.
• W4224870304 creator A5022837969 @default.
• W4224870304 creator A5034686146 @default.
• W4224870304 creator A5040416679 @default.
• W4224870304 creator A5040862363 @default.
• W4224870304 creator A5052412073 @default.
• W4224870304 creator A5054213833 @default.
• W4224870304 creator A5071009213 @default.
• W4224870304 creator A5072774443 @default.
• W4224870304 creator A5081502580 @default.
• W4224870304 creator A5082924617 @default.
• W4224870304 date "2022-08-01" @default.
• W4224870304 modified "2023-10-17" @default.
• W4224870304 title "Immunophenotype of Lacrimal Glands in Graves Orbitopathy: Implications for the Pathogenesis of Th1 and Th17 Immunity" @default.
• W4224870304 cites W1973615601 @default.
• W4224870304 cites W1978662104 @default.
• W4224870304 cites W1980415472 @default.
• W4224870304 cites W1988357261 @default.
• W4224870304 cites W1990818285 @default.
• W4224870304 cites W2046450773 @default.
• W4224870304 cites W2050717908 @default.
• W4224870304 cites W2066703536 @default.
• W4224870304 cites W2111585147 @default.
• W4224870304 cites W2137390873 @default.
• W4224870304 cites W2167635924 @default.
• W4224870304 cites W2401775050 @default.
• W4224870304 cites W2530255275 @default.
• W4224870304 cites W2551271915 @default.
• W4224870304 cites W2552640581 @default.
• W4224870304 cites W2562601801 @default.
• W4224870304 cites W2568452461 @default.
• W4224870304 cites W2585368532 @default.
• W4224870304 cites W2607143083 @default.
• W4224870304 cites W2734752050 @default.
• W4224870304 cites W2750317963 @default.
• W4224870304 cites W2751407442 @default.
• W4224870304 cites W2793302312 @default.
• W4224870304 cites W2855676216 @default.
• W4224870304 cites W2902638510 @default.
• W4224870304 cites W2903723179 @default.
• W4224870304 cites W2905348379 @default.
• W4224870304 cites W2906051248 @default.
• W4224870304 cites W2939946042 @default.
• W4224870304 cites W2947549828 @default.
• W4224870304 cites W2996557013 @default.
• W4224870304 cites W2998265514 @default.
• W4224870304 cites W3011765220 @default.
• W4224870304 cites W3092331170 @default.
• W4224870304 cites W3120717168 @default.
• W4224870304 cites W3122872001 @default.
• W4224870304 cites W3127356538 @default.
• W4224870304 cites W312926527 @default.
• W4224870304 cites W3140242758 @default.
• W4224870304 cites W3150034268 @default.
• W4224870304 cites W3153810019 @default.
• W4224870304 cites W3214207340 @default.
• W4224870304 doi "https://doi.org/10.1089/thy.2021.0671" @default.
• W4224870304 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35469435" @default.
• W4224870304 hasPublicationYear "2022" @default.
• W4224870304 type Work @default.
• W4224870304 citedByCount "5" @default.
• W4224870304 countsByYear W42248703042022 @default.
• W4224870304 countsByYear W42248703042023 @default.
• W4224870304 crossrefType "journal-article" @default.
• W4224870304 hasAuthorship W4224870304A5003642180 @default.
• W4224870304 hasAuthorship W4224870304A5022147066 @default.
• W4224870304 hasAuthorship W4224870304A5022837969 @default.
• W4224870304 hasAuthorship W4224870304A5034686146 @default.
• W4224870304 hasAuthorship W4224870304A5040416679 @default.
• W4224870304 hasAuthorship W4224870304A5040862363 @default.
• W4224870304 hasAuthorship W4224870304A5052412073 @default.
• W4224870304 hasAuthorship W4224870304A5054213833 @default.
• W4224870304 hasAuthorship W4224870304A5071009213 @default.
• W4224870304 hasAuthorship W4224870304A5072774443 @default.
• W4224870304 hasAuthorship W4224870304A5081502580 @default.
• W4224870304 hasAuthorship W4224870304A5082924617 @default.
• W4224870304 hasConcept C142724271 @default.
• W4224870304 hasConcept C151730666 @default.
• W4224870304 hasConcept C196166836 @default.
• W4224870304 hasConcept C203014093 @default.
• W4224870304 hasConcept C2776652619 @default.
• W4224870304 hasConcept C2776685619 @default.
• W4224870304 hasConcept C2778690821 @default.
• W4224870304 hasConcept C2779134260 @default.
• W4224870304 hasConcept C2779298748 @default.
• W4224870304 hasConcept C2779343474 @default.
• W4224870304 hasConcept C553184892 @default.
• W4224870304 hasConcept C71924100 @default.
• W4224870304 hasConcept C74172505 @default.
• W4224870304 hasConcept C86803240 @default.
• W4224870304 hasConceptScore W4224870304C142724271 @default.
• W4224870304 hasConceptScore W4224870304C151730666 @default.
• W4224870304 hasConceptScore W4224870304C196166836 @default.
• W4224870304 hasConceptScore W4224870304C203014093 @default.
• W4224870304 hasConceptScore W4224870304C2776652619 @default.

• next